Drug Shortage Report for ATORVASTATIN
| Report ID | 98790 |
| Drug Identification Number | 02399385 |
| Brand name | ATORVASTATIN |
| Common or Proper name | ATORVASTATIN |
| Company Name | PHARMASCIENCE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-01-03 |
| Actual start date | |
| Estimated end date | 2020-02-03 |
| Actual end date | 2020-07-22 |
| Shortage status | Resolved |
| Updated date | 2020-07-23 |
| Company comments | Transition to DIN 02477157 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2020-07-23 | French | Compare |
| v9 | 2020-07-23 | English | Compare |
| v8 | 2020-01-04 | English | Compare |
| v7 | 2019-12-24 | French | Compare |
| v6 | 2019-12-24 | English | Compare |
| v5 | 2019-12-17 | English | Compare |
| v4 | 2019-11-19 | French | Compare |
| v3 | 2019-11-19 | English | Compare |
| v2 | 2019-11-15 | French | Compare |
| v1 | 2019-11-15 | English | Compare |
Showing 1 to 10 of 10